| Increased access to transplantation for blood group B cadaveric waiting list candidates by using A2 kidneys: time for a new national system? PW Nelsona, CF Shield III, NA Muruve, D Murillo, BA Warady, MI Aeder, ... American Journal of Transplantation 2 (1), 94-99, 2002 | 61 | 2002 |
| Improving access to kidney transplantation without decreasing graft survival: long-term outcomes of blood group A2/A2B deceased donor kidneys in B recipients CF Bryan, FT Winklhofer, D Murillo, G Ross, PW Nelson, CF Shield III, ... Transplantation 80 (1), 75-80, 2005 | 47 | 2005 |
| Double renal transplants from marginal donors: 2-year results JT JERIUS, RJ TAYLOR, D MURILLO, JP LEONE The Journal of urology 163 (2), 423-425, 2000 | 46 | 2000 |
| Influence of pill burden and drug cost on renal function after transplantation KL Hardinger, T Hutcherson, D Preston, D Murillo Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32 (5 …, 2012 | 38 | 2012 |
| Adverse drug reaction driven immunosuppressive drug manipulations: a single‐center comparison of enteric‐coated mycophenolate sodium vs. mycophenolate mofetil KL Hardinger, S Hebbar, T Bloomer, D Murillo Clinical transplantation 22 (5), 555-561, 2008 | 37 | 2008 |
| Long-term survival of kidneys transplanted from live A2 donors to O and B recipients CF Bryan, PW Nelson, CF Shield, BA Warady, FT Winklhofer, D Murillo, ... American journal of transplantation 7 (5), 1181-1184, 2007 | 35 | 2007 |
| Renal graft survival is not influenced by a positive flow B‐cell crossmatch CF Bryan, M Wakefield, JC Reese, CF Shield III, BA Warady, ... Clinical transplantation 21 (1), 72-79, 2007 | 27 | 2007 |
| Sharing kidneys across donor‐service area boundaries with sensitized candidates can be influenced by HLA C CF Bryan, AM Luger, JL Smith, BA Warady, M Wakefield, E Schadde, ... Clinical transplantation 24 (1), 56-61, 2010 | 26 | 2010 |
| Transplantation of A2 and A2B kidneys from deceased donors into B waiting list candidates increases their transplantation rate. CF Bryan, PW Nelson, CF Shield 3rd, G Ross, B Warady, D Murillo, ... Clinical Transplants, 127-133, 2004 | 24 | 2004 |
| Successful renal transplantation despite low levels of donor‐specific HLA class I antibody without IVIg or plasmapheresis CF Bryan, SB McDonald, AM Luger, CF Shield, FT Winklhofer, ... Clinical transplantation 20 (5), 563-570, 2006 | 20 | 2006 |
| HLA points assigned in cadaveric kidney allocation should be revisited: an analysis of HLA class II molecularly typed patients and donors CF Bryan, KM Harrell, SI Mitchell, BA Warady, MI Aeder, AM Luger, ... American Journal of Transplantation 3 (4), 459-464, 2003 | 18 | 2003 |
| The risk for Chagas' disease in the Midwestern United States organ donor population is low CF Bryan, GE Tegtmeier, N Rafik, LE Markham, D Murillo, PW Nelson, ... Clinical transplantation 18, 12-15, 2004 | 16 | 2004 |
| Bortezomib for acute humoral rejection in two repeat transplant recipients. KL Hardinger, K Alford, D Murillo Clinical Transplants, 479-483, 2009 | 14 | 2009 |
| Point‐of‐care testing in an organ procurement organization donor management setting KA Baier, LE Markham, SP Flaigle, PW Nelson, CF Shield, NA Muruve, ... Clinical transplantation 17, 48-51, 2003 | 14 | 2003 |
| Flow cytometry beads rather than the antihuman globulin method should be used to detect HLA class I IgG antibody (PRA) in cadaveric renal regraft candidates CF Bryan, SB McDonald, KA Baier, AM Luger, MI Aeder, D Murillo, ... Clinical transplantation 16, 15-23, 2002 | 11 | 2002 |
| Donor-specific antibodies present at the time of kidney transplantation in immunologically unmodified patients increase the risk of acute rejection A Gupta, D Murillo, SG Yarlagadda, CJ Wang, A Nawabi, T Schmitt, ... Transplant Immunology 37, 18-22, 2016 | 10 | 2016 |
| Bortezomib as rescue therapy for antibody mediated rejection: a single-center experience. KL Hardinger, K Alford, D Murillo Clinical Transplants, 429-436, 2010 | 9 | 2010 |
| Nationwide molecular survey of Dirofilaria immitis and Dirofilaria repens in companion dogs and cats, United States of America R Smith, DFB Murillo, K Chenoweth, S Barua, PJ Kelly, L Starkey, ... Parasites & Vectors 15 (1), 367, 2022 | 8 | 2022 |
| A new role for the virtual crossmatch in kidney allograft reuse CF Bryan, B Abdulkarim, J Forster, PW Nelson, D Diederich, D Murillo, ... Transplantation 89 (6), 764-765, 2010 | 7 | 2010 |
| The influence of bortezomib on donor specific antibody reduction in patients with antibody mediated rejection. KL Hardinger, D Murillo Clinical Transplants, 401-408, 2011 | 6 | 2011 |
